Table 2. Demographics and clinicopathological variables of metastatic bladder cancer cohort and healthy donor controls.
| Pt Identifier—Age—Sex | Chemotherapy History | Metastatic Sites | Prior Cystectomy |
|---|---|---|---|
| Metastatic: | |||
| Met1–61–M | 1st Line | Lymph nodes, bone, viscera | No |
| Met2–68–M | More than 2 lines | Lymph nodes, bone. viscera | Yes |
| Met3-–6–F | 1st Line | Lymph nodes, viscera | No |
| Met4–70–M | 2nd Line | Lymph nodes | No |
| Met5–66–M | 1st Line | Lymph nodes, bone, viscera | Yes |
| Met6–71–M | Not applicable | No | |
| Met7–73–F | 2nd Line | Lymph nodes, bone | Yes |
| Met8–61–M | Naïve | Viscera | No |
| Met9–81–M | Naïve | Lymph nodes, bone | No |
| Met10–43–M | 2nd Line | Lymph nodes, viscera | Yes |
| Met11–75–M | 1st Line | Viscera | No |
| Control: | – | – | – |
| HD1–22–M | |||
| HD2–22–M | |||
| HD3–44–M | |||
| HD4–44–M | |||
| HD5–26–M | |||
| HD6–30–M | |||
| HD7–30–M | |||
| HD8–54–M | |||
| HD9–27–M | |||
| HD10–26–M | |||
| HD11–24–M | |||
| HD12–36–M | |||
| HD13–36–M | |||